These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 9813922

  • 21. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group.
    White CJ, Stinson D, Staehle B, Cho I, Matthews H, Ngai A, Keller P, Eiden J, Kuter B.
    Clin Infect Dis; 1997 May; 24(5):925-31. PubMed ID: 9142794
    [Abstract] [Full Text] [Related]

  • 22. Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection.
    Cilla G, Peña B, Marimón JM, Pérez-Trallero E.
    Vaccine; 1996 Apr; 14(6):492-4. PubMed ID: 8782345
    [Abstract] [Full Text] [Related]

  • 23. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up.
    Davidkin I, Valle M, Julkunen I.
    Vaccine; 1995 Nov; 13(16):1617-22. PubMed ID: 8578851
    [Abstract] [Full Text] [Related]

  • 24. Previous exposure to measles, mumps, and rubella--but not vaccination during adolescence--correlates to the prevalence of pancreatic and thyroid autoantibodies.
    Lindberg B, Ahlfors K, Carlsson A, Ericsson UB, Landin-Olsson M, Lernmark A, Ludvigsson J, Sundkvist G, Ivarsson SA.
    Pediatrics; 1999 Jul; 104(1):e12. PubMed ID: 10390298
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
    Pauksen K, Duraj V, Ljungman P, Sjölin J, Oberg G, Lönnerholm G, Fridell E, Smedmyr B, Simonsson B.
    Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126
    [Abstract] [Full Text] [Related]

  • 27. Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule.
    Christenson B, Böttiger M.
    Vaccine; 1991 May; 9(5):326-9. PubMed ID: 1872016
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of mumps antibodies after measles-mumps-rubella (MMR) vaccines.
    Ozaki K, Kuno-Sakai H, Kimura M.
    Tokai J Exp Clin Med; 1987 Dec; 12(5-6):305-11. PubMed ID: 3508655
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia.
    Feldman S, Andrew M, Norris M, McIntyre B, Iyer R.
    Clin Infect Dis; 1998 Aug; 27(2):388-90. PubMed ID: 9709893
    [Abstract] [Full Text] [Related]

  • 31. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis.
    Flynn JT, Frisch K, Kershaw DB, Sedman AB, Bunchman TE.
    Adv Perit Dial; 1999 Aug; 15():269-72. PubMed ID: 10682116
    [Abstract] [Full Text] [Related]

  • 32. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM, Saunders EF, Petric M, Gold R.
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [Abstract] [Full Text] [Related]

  • 33. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM, Baker L, Starr SE, Plotkin SA.
    Dev Biol Stand; 1986 Apr; 65():89-93. PubMed ID: 3030864
    [Abstract] [Full Text] [Related]

  • 34. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
    Pisón Garcés FJ, Galbe Sánchez-Ventura J, Arcauz Eguren P, Aguirre y Dabán C, Mengual Gil J, Larrad Mur L.
    Aten Primaria; 1995 Mar 15; 15(4):235-7. PubMed ID: 7703334
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reactogenicity and immunogenicity of a new combined measles-mumps-rubella vaccine: results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines.
    Crovari P, Gabutti G, Giammanco G, Dentico P, Moiraghi AR, Ponzio F, Soncini R.
    Vaccine; 2000 Jun 15; 18(25):2796-803. PubMed ID: 10812221
    [Abstract] [Full Text] [Related]

  • 39. Sex differences in antibody- and cell-mediated immune response to rubella re-immunisation.
    Mitchell LA.
    J Med Microbiol; 1999 Dec 15; 48(12):1075-1080. PubMed ID: 10591160
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.